Notice2021-26954

Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID)

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
December 14, 2021

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Abstract

In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Deputy Director for Infectious Diseases (BSC, DDID). This virtual meeting is open to the public via Zoom, limited only by the space available, which is 500 seats. Pre-registration is required by accessing the link below in the addresses section.

Full Text

<html>
<head>
<title>Federal Register, Volume 86 Issue 237 (Tuesday, December 14, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 237 (Tuesday, December 14, 2021)]
[Notices]
[Page 71068]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-26954]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Deputy Director for Infectious 
Diseases (BSC, DDID)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
Deputy Director for Infectious Diseases (BSC, DDID). This virtual 
meeting is open to the public via Zoom, limited only by the space 
available, which is 500 seats. Pre-registration is required by 
accessing the link below in the addresses section.

DATES: The meeting will be held on January 19-20, 2022, from 1:00 p.m. 
to 5:30 p.m., EST.

ADDRESSES: Zoom virtual meeting. Pre-registration is required by 
accessing the link at <a href="https://cdc.zoomgov.com/webinar/register/WN_vXuOtDbNQIycPMScOPKvKQ">https://cdc.zoomgov.com/webinar/register/WN_vXuOtDbNQIycPMScOPKvKQ</a>. Instructions to access the meeting will be 
provided following registration.

FOR FURTHER INFORMATION CONTACT: Hilary Eiring, MPH, Designated Federal 
Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia 
30329-4027, Telephone: (770) 488-3901; Email: <a href="/cdn-cgi/l/email-protection#d59d90bca7bcbbb295b6b1b6fbb2baa3"><span class="__cf_email__" data-cfemail="5018153922393e37103334337e373f26">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION:
    Purpose: The Board provides advice and guidance to the Secretary, 
Department of Health and Human Services; the Director, CDC; the 
Director and the Deputy Director for Infectious Diseases (DDID), CDC; 
and the Directors of the National Center for Emerging and Zoonotic 
Infectious Diseases, the National Center for HIV, Viral Hepatitis, STD, 
and TB Prevention, and the National Center for Immunization and 
Respiratory Diseases, CDC, in the following areas: Strategies, goals, 
and priorities for programs and research within the national centers 
and monitor the overall strategic direction and focus of DDID and the 
national centers.
    Matters To Be Considered: The agenda will include updates and 
discussions on recent outbreaks; updates and discussions on CDC's 
Center for Forecasting and Outbreak Analytics, advanced molecular 
detection program, Data Modernization Initiative, and CORE Health 
Equity Science and Intervention Strategy; and other updates and 
reports, including a brief report back from the Board's Food Safety 
Modernization Act Surveillance Working Group. Agenda items are subject 
to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-26954 Filed 12-13-21; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on December 14, 2021.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.